Blepharospasm and autoimmune diseases.
Identifieur interne : 005057 ( PubMed/Corpus ); précédent : 005056; suivant : 005058Blepharospasm and autoimmune diseases.
Auteurs : J. Jankovic ; B M PattenSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 1987.
English descriptors
- KwdEn :
- Adult, Antibodies, Antinuclear (analysis), Autoantibodies (analysis), Blepharospasm (drug therapy), Blepharospasm (etiology), Cyclophosphamide (administration & dosage), Eyelid Diseases (etiology), Female, Humans, Lupus Erythematosus, Systemic (complications), Lupus Erythematosus, Systemic (drug therapy), Methylprednisolone (administration & dosage), Middle Aged, Myasthenia Gravis (complications), Myasthenia Gravis (drug therapy), Prednisone (administration & dosage).
- MESH :
- chemical , administration & dosage : Cyclophosphamide, Methylprednisolone, Prednisone.
- chemical , analysis : Antibodies, Antinuclear, Autoantibodies.
- complications : Lupus Erythematosus, Systemic, Myasthenia Gravis.
- drug therapy : Blepharospasm, Lupus Erythematosus, Systemic, Myasthenia Gravis.
- etiology : Blepharospasm, Eyelid Diseases.
- Adult, Female, Humans, Middle Aged.
Abstract
We studied two patients, one with systemic lupus erythematosus and the other with myasthenia gravis, both of whom had coexistent blepharospasm. The blepharospasm occurred during exacerbations of the autoimmune diseases and improved with immunosuppressive therapy. These cases illustrate the possible association of blepharospasm and autoimmune disorders.
DOI: 10.1002/mds.870020303
PubMed: 3509774
Links to Exploration step
pubmed:3509774Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Blepharospasm and autoimmune diseases.</title>
<author><name sortKey="Jankovic, J" sort="Jankovic, J" uniqKey="Jankovic J" first="J" last="Jankovic">J. Jankovic</name>
<affiliation><nlm:affiliation>Department of Neurology, Baylor College of Medicine, Houston, Texas 77030.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Patten, B M" sort="Patten, B M" uniqKey="Patten B" first="B M" last="Patten">B M Patten</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1987">1987</date>
<idno type="RBID">pubmed:3509774</idno>
<idno type="pmid">3509774</idno>
<idno type="doi">10.1002/mds.870020303</idno>
<idno type="wicri:Area/PubMed/Corpus">005057</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Blepharospasm and autoimmune diseases.</title>
<author><name sortKey="Jankovic, J" sort="Jankovic, J" uniqKey="Jankovic J" first="J" last="Jankovic">J. Jankovic</name>
<affiliation><nlm:affiliation>Department of Neurology, Baylor College of Medicine, Houston, Texas 77030.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Patten, B M" sort="Patten, B M" uniqKey="Patten B" first="B M" last="Patten">B M Patten</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1987" type="published">1987</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antibodies, Antinuclear (analysis)</term>
<term>Autoantibodies (analysis)</term>
<term>Blepharospasm (drug therapy)</term>
<term>Blepharospasm (etiology)</term>
<term>Cyclophosphamide (administration & dosage)</term>
<term>Eyelid Diseases (etiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Lupus Erythematosus, Systemic (complications)</term>
<term>Lupus Erythematosus, Systemic (drug therapy)</term>
<term>Methylprednisolone (administration & dosage)</term>
<term>Middle Aged</term>
<term>Myasthenia Gravis (complications)</term>
<term>Myasthenia Gravis (drug therapy)</term>
<term>Prednisone (administration & dosage)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cyclophosphamide</term>
<term>Methylprednisolone</term>
<term>Prednisone</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Antibodies, Antinuclear</term>
<term>Autoantibodies</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Lupus Erythematosus, Systemic</term>
<term>Myasthenia Gravis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Blepharospasm</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Myasthenia Gravis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Blepharospasm</term>
<term>Eyelid Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We studied two patients, one with systemic lupus erythematosus and the other with myasthenia gravis, both of whom had coexistent blepharospasm. The blepharospasm occurred during exacerbations of the autoimmune diseases and improved with immunosuppressive therapy. These cases illustrate the possible association of blepharospasm and autoimmune disorders.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">3509774</PMID>
<DateCreated><Year>1989</Year>
<Month>01</Month>
<Day>19</Day>
</DateCreated>
<DateCompleted><Year>1989</Year>
<Month>01</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>2</Volume>
<Issue>3</Issue>
<PubDate><Year>1987</Year>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Blepharospasm and autoimmune diseases.</ArticleTitle>
<Pagination><MedlinePgn>159-63</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We studied two patients, one with systemic lupus erythematosus and the other with myasthenia gravis, both of whom had coexistent blepharospasm. The blepharospasm occurred during exacerbations of the autoimmune diseases and improved with immunosuppressive therapy. These cases illustrate the possible association of blepharospasm and autoimmune disorders.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jankovic</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Baylor College of Medicine, Houston, Texas 77030.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Patten</LastName>
<ForeName>B M</ForeName>
<Initials>BM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>UNITED STATES</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000974">Antibodies, Antinuclear</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>8N3DW7272P</RegistryNumber>
<NameOfSubstance UI="D003520">Cyclophosphamide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>VB0R961HZT</RegistryNumber>
<NameOfSubstance UI="D011241">Prednisone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber>
<NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000974">Antibodies, Antinuclear</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001323">Autoantibodies</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001764">Blepharospasm</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003520">Cyclophosphamide</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005141">Eyelid Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008180">Lupus Erythematosus, Systemic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008775">Methylprednisolone</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009157">Myasthenia Gravis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011241">Prednisone</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1987</Year>
<Month>1</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1987</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1987</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">3509774</ArticleId>
<ArticleId IdType="doi">10.1002/mds.870020303</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005057 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 005057 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:3509774 |texte= Blepharospasm and autoimmune diseases. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:3509774" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |